Valeo Financial Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.53M | Buy |
24,477
+721
| +3% | +$64.4K | 0.05% | 147 |
|
|
2026
Q1 | $1.71M | Sell |
23,756
-8,881
| -27% | -$684K | 0.04% | 181 |
|
|
2025
Q4 | $2.59M | Buy |
32,637
+1,475
| +5% | +$116K | 0.06% | 149 |
|
|
2025
Q3 | $2.35M | Buy |
31,162
+4,389
| +16% | +$301K | 0.05% | 148 |
|
|
2025
Q2 | $1.85M | Sell |
26,773
-3,716
| -12% | -$244K | 0.05% | 186 |
|
|
2025
Q1 | $2.07M | Buy |
30,489
+1,532
| +5% | +$91.7K | 0.06% | 154 |
|
|
2024
Q4 | $1.3M | Buy |
28,957
+500
| +2% | +$28.1K | 0.04% | 205 |
|
|
2024
Q3 | $1.79M | Sell |
28,457
-4,355
| -13% | -$254K | 0.05% | 171 |
|
|
2024
Q2 | $1.94M | Sell |
32,812
-6,223
| -16% | -$389K | 0.06% | 150 |
|
|
2024
Q1 | $2.65M | Sell |
39,035
-10,141
| -21% | -$775K | 0.09% | 115 |
|
|
2023
Q4 | $3.88M | Sell |
49,176
-1,516
| -3% | -$108K | 0.16% | 76 |
|
|
2023
Q3 | $3.54M | Sell |
50,692
-21,558
| -30% | -$1.53M | 0.16% | 77 |
|
|
2023
Q2 | $4.99M | Buy |
72,250
+12,037
| +20% | +$856K | 0.23% | 59 |
|
|
2023
Q1 | $4.47M | Buy |
60,213
+6,415
| +12% | +$538K | 0.22% | 66 |
|
|
2022
Q4 | $5.01M | Buy |
53,798
+2,750
| +5% | +$265K | 0.28% | 54 |
|
|
2022
Q3 | $4.87M | Sell |
51,048
-4,973
| -9% | -$492K | 0.31% | 49 |
|
|
2022
Q2 | $5.19M | Sell |
56,021
-534
| -0.9% | -$52.1K | 0.33% | 51 |
|
|
2022
Q1 | $5.72M | Sell |
56,555
-3,755
| -6% | -$394K | 0.29% | 54 |
|
|
2021
Q4 | $6.22M | Sell |
60,310
-1,455
| -2% | -$134K | 0.34% | 43 |
|
|
2021
Q3 | $5.24M | Buy |
61,765
+4,034
| +7% | +$338K | 0.3% | 48 |
|
|
2021
Q2 | $4.82M | Sell |
57,731
-2,168
| -4% | -$178K | 0.29% | 55 |
|
|
2021
Q1 | $4.51M | Sell |
59,899
-44,348
| -43% | -$3.23M | 0.21% | 61 |
|
|
2020
Q4 | $3.81M | Buy |
104,247
+49,262
| +90% | +$3.2M | 0.2% | 64 |
|
|
2020
Q3 | $3.21M | Buy |
54,985
+4,725
| +9% | +$294K | 0.28% | 55 |
|
|
2020
Q2 | $3.27M | Buy |
50,260
+1,274
| +3% | +$80.2K | 0.3% | 49 |
|
|
2020
Q1 | $2.96M | Sell |
48,986
-3,901
| -7% | -$260K | 0.31% | 48 |
|
|
2019
Q4 | $3.93M | Sell |
52,887
-1,749
| -3% | -$123K | 0.38% | 45 |
|
|
2019
Q3 | $3.44M | Sell |
54,636
-925
| -2% | -$54.8K | 0.38% | 46 |
|
|
2019
Q2 | $3.03M | Buy |
55,561
+11,098
| +25% | +$598K | 0.35% | 48 |
|
|
2019
Q1 | $2.4M | Buy |
44,463
+29,886
| +205% | +$1.84M | 0.29% | 58 |
|
|
2018
Q4 | $955K | Buy |
14,577
+6,953
| +91% | +$519K | 0.13% | 114 |
|
|
2018
Q3 | $552K | Sell |
7,624
-3,159
| -29% | -$226K | 0.07% | 166 |
|
|
2018
Q2 | $748K | Sell |
10,783
-8,243
| -43% | -$543K | 0.1% | 133 |
|
|
2018
Q1 | $1.18M | Buy |
19,026
+14,732
| +343% | +$1.06M | 0.19% | 89 |
|
|
2017
Q4 | $311K | Buy |
4,294
+2,337
| +119% | +$170K | 0.05% | 190 |
|
|
2017
Q3 | $159K | Buy |
+1,957
| New | +$155K | 0.04% | 226 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
MIF
Valeo Financial Advisors's CVS Position: Q2 2026 in Review
Valeo Financial Advisors increased its CVS Health (CVS) stake by 3% in Q2 2026, buying an estimated $64.4K and bringing the position to 24,477 shares worth $2.53M. The position accounts for 0.05% of the portfolio, ranked #147.
Valeo Financial Advisors first reported a position in CVS in Q3 2017 and has held it in 36 quarters since. The position peaked at $6.22M in Q4 2021. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Valeo Financial Advisors held 24,477 shares of CVS Health worth $2.53M as of Q2 2026.
- Valeo Financial Advisors bought 721 CVS Health shares in Q2 2026, an estimated $64.4K.
- CVS Health made up 0.05% of Valeo Financial Advisors's portfolio in Q2 2026, its #147 holding.
- Valeo Financial Advisors first reported a position in CVS Health in Q3 2017 and has held it in 36 quarters since.
- Valeo Financial Advisors's CVS Health position peaked at $6.22M in Q4 2021.
- 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.